Polmacoxib

Polmacoxib
Clinical data
Trade names Acelex
Identifiers
Synonyms CG100649
CAS Number 301692-76-2
PubChem (CID) 9841854
ChemSpider 8017569
UNII IJ34D6YPAO
ChEMBL CHEMBL166863
Chemical and physical data
Formula C12H16FNO4S
Molar mass 361.3914 g/mol
3D model (Jmol) Interactive image

Polmacoxib (Acelex) is a nonsteroidal anti-inflammatory drug (NSAID) used to treat osteoarthritis. It was developed as CG100649 and approved for use in South Korea in February 2015.[1] It inhibits the enzymes carbonic anhydrase and COX-2. A study in healthy volunteers showed drug effects on urinary prostaglandin metabolites for both CG100649 and celecoxib that suggest a similar cardiovascular risk profile.[2] Further work by this group developed dose-exposure relationsships of CG100649 to guide clinical development strategies. [3]

See also

References



This article is issued from Wikipedia - version of the 4/19/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.